Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / Unlocking Hidden RNA Signals
Biochemistry and molecular biology Genetics and epigenetics Insights

Unlocking Hidden RNA Signals

Targeted sequencing aids rare disease diagnosis

04/30/2026 News 3 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Top Institutions

Share

Top Institutions in Genomic Medicine and RNA Sequencing

Leading institutions in genomic medicine employ cutting-edge sequencing technologies, including long-read RNA sequencing and integrated bioinformatics workflows, to analyze full-length RNA transcripts and their effects on gene expression and splicing. These centers combine clinical genomics expertise with translational research to develop and validate novel diagnostic approaches for rare diseases.

  • #1

    Broad Institute of MIT and Harvard

    Cambridge, MA

    The Broad Institute is a global leader in genomic research and technology development, with extensive expertise in long-read sequencing and RNA analysis. Their collaborative efforts with clinical partners enable rapid translation of sequencing innovations into diagnostic tools for rare diseases.

    Key Differentiators

    • Genomic Medicine
    • RNA Sequencing
    • Rare Disease Diagnostics
  • #2

    National Institutes of Health (NIH) - National Human Genome Research Institute (NHGRI)

    Bethesda, MD

    NHGRI leads federally funded research on genome sequencing technologies and their clinical applications, including the development of targeted RNA sequencing methods to improve variant interpretation in rare diseases.

    Key Differentiators

    • Genomic Medicine
    • RNA Biology
    • Clinical Genomics
  • #3

    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    UCSF is recognized for its clinical and research programs in genomic medicine, utilizing advanced RNA sequencing technologies to diagnose and understand rare genetic disorders, with a focus on integrating sequencing data into clinical workflows.

    Key Differentiators

    • Clinical Genomics
    • RNA Sequencing
    • Rare Disease Diagnostics
  • #4

    Mayo Clinic

    Rochester, MN

    Mayo Clinic integrates advanced genomic technologies including targeted RNA sequencing into its molecular diagnostics services, supporting comprehensive evaluation of genetic variants in rare disease patients.

    Key Differentiators

    • Genomic Medicine
    • Molecular Diagnostics
    • RNA Sequencing
  • #5

    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    CHOP is a leader in pediatric genomic medicine, employing innovative RNA sequencing approaches to improve diagnosis and understanding of rare genetic disorders in children.

    Key Differentiators

    • Pediatric Genomics
    • RNA Sequencing
    • Rare Disease Diagnostics

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.